Filing acceptance based on phase III data showing giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1-mutated populations, respectively, versus ...

We were honored to receive the 2025 Clinical Trials Arena R&D Excellence Award in the Precision Endocrine Therapy category, reflecting growing awareness of the utility of (Z)-endoxifen across oncology ...

Incyte Corporation (NASDAQ:INCY) Q4 2025 Earnings Call Transcript February 10, 2026 Incyte Corporation misses on earnings ...

Designation supported by robust clinical data from ReDiscover trial with 600mg BID fasted and 400mg BID fed doses of zovegalisib in combination ...

Anu Roberts shares how CDK’s built-in CDP and AI tools help dealers unify data, streamline workflows, and boost sales and retention.

A report by Mitchell found that repair costs for EVs have dipped slightly. That should give current owners a little more ...

Leading automotive retail software provider recognized with top honors for customer service training and enterprise transformation CDK, the leading automotive retail software provider, today announced ...

Even as excitement builds about mega IPOs, the collapse in the share prices of software companies means bankers will have to ...

Filing acceptance based on phase III data showing giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1-mutated populations, respectively, versus ...

A UN report reveals how AI driven cyber scam centers in Myanmar, Cambodia, and Laos traffic over 300,000 people into global ...

In 2025 Lyrical Global generated a 21.1% return, in line with the MSCI World Index and slightly ahead of the MSCI World Value Index. The MSCI EAFE delivered a 31.2% return, finally closing some of the ...

Canopy Growth Corporation (NASDAQ:CGC) is among the 7 Best Cannabis Stocks to Invest In Now. Canopy Growth Corporation ...